SpaceGen Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$15.3M
- Investors
-
5
SpaceGen General Information
Description
Developer, manufacturer and retailer of medical products and services for cancer, genetic diseases and other personalized precision medical testing. The company has developed 32 clinical-grade detection kits for lung cancer, breast cancer and colon cancer, providing medical workers and patients with professional and high-quality precision medical solutions.
Contact Information
Website
www.ispacegen.comCorporate Office
- 7th Floor, Building 2, Taipu Science Park
- No. 2041 Xizhou Road, Xike Town, Tong'an District
- Xiamen, Fujian 361100
- China
Corporate Office
- 7th Floor, Building 2, Taipu Science Park
- No. 2041 Xizhou Road, Xike Town, Tong'an District
- Xiamen, Fujian 361100
- China
SpaceGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 30-Dec-2020 | $15.3M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 01-Sep-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 01-Aug-2016 | $1.5M | $3.02M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Feb-2016 | $1.52M | $1.52M | Completed | Startup |
SpaceGen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SpaceGen Patents
SpaceGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12553152-B2 | Library construction method for detecting endometrial cancer-related gene mutations based on high-throughput sequencing | Active | 30-Sep-2020 | ||
| US-20220307016-A1 | Library construction method for detecting endometrial cancer-related gene mutations based on high-throughput sequencing | Active | 30-Sep-2020 | ||
| WO-2022067938-A1 | Library construction method for detecting endometrial cancer-related gene mutations based on high-throughput sequencing | Inactive | 30-Sep-2020 | ||
| WO-2022067936-A1 | Method for constructing library for detecting fgfr1/2/3 fusion gene of cholangiocarcinoma on basis of high-throughput sequencing | Inactive | 30-Sep-2020 | ||
| WO-2017024690-A1 | Construction method for a single tube high-throughput sequencing library | Inactive | 13-Aug-2015 | C40B50/06 |
SpaceGen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SpaceGen Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DYEE Capital | Asset Manager | Minority | ||
| Yangming Capital | Venture Capital | Minority | ||
| Prosperico Ventures | Venture Capital | Minority | ||
| Darui Biotechnology | VC-Backed Company | Minority | ||
| Qiaojing Capital | Venture Capital | Minority |
SpaceGen FAQs
-
When was SpaceGen founded?
SpaceGen was founded in 2015.
-
Where is SpaceGen headquartered?
SpaceGen is headquartered in Xiamen, China.
-
What is the size of SpaceGen?
SpaceGen has 41 total employees.
-
What industry is SpaceGen in?
SpaceGen’s primary industry is Diagnostic Equipment.
-
Is SpaceGen a private or public company?
SpaceGen is a Private company.
-
What is SpaceGen’s current revenue?
The current revenue for SpaceGen is .
-
How much funding has SpaceGen raised over time?
SpaceGen has raised $24.3M.
-
Who are SpaceGen’s investors?
DYEE Capital, Yangming Capital, Prosperico Ventures, Darui Biotechnology, and Qiaojing Capital have invested in SpaceGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
